Hobbs Group Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-90
Closed -$10.4K 458
2024
Q3
$10.4K Hold
90
﹤0.01% 417
2024
Q2
$9.58K Buy
+90
New +$9.03K ﹤0.01% 391
2023
Q4
$9.09K Buy
+90
New +$8.69K ﹤0.01% 365

Other funds holding NVS

Hobbs Group Advisors's NVS Position: Q4 2024 in Review

Hobbs Group Advisors sold out of Novartis (NVS) in Q4 2024, closing a stake of 90 shares — an estimated $10.4K sold.

Hobbs Group Advisors first reported a position in NVS in Q4 2023 and held it in 3 quarters. The position peaked at $10.4K in Q3 2024. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Hobbs Group Advisors reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Hobbs Group Advisors sold 90 Novartis shares in Q4 2024, an estimated $10.4K.
  • Hobbs Group Advisors first reported a position in Novartis in Q4 2023 and held it in 3 quarters.
  • Hobbs Group Advisors's Novartis position peaked at $10.4K in Q3 2024.
  • 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.